VERV

Verve Therapeutics
VERV

Overview Fund Activity
Delisted

VERV was delisted on the 24th of July, 2025.

Back to rankings

192 hedge funds and large institutions have $369M invested in Verve Therapeutics in 2025 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 54 increasing their positions, 64 reducing their positions, and 16 closing their positions.

Holders
192
Holders Change
+26
Holders Change %
+15.66%
% of All Funds
2.61%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
43
Increased
54
Reduced
64
Closed
16
Calls
$1.09M
Puts
$348K
Net Calls
+$740K
Net Calls Change
+$932K

Top Buyers

1
WP
1
Woodline Partners
California
$12.6M
2
Bank of America
2
Bank of America
North Carolina
$7.46M
3
FCM
3
Farallon Capital Management
California
$4.17M
4
Goldman Sachs
4
Goldman Sachs
New York
$6.46M
5
NHAS
5
Novo Holdings A/S
Denmark
$13.7M

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$9.65M
2
Jacobs Levy Equity Management
2
Jacobs Levy Equity Management
New Jersey
$2.98M
3
SSA
3
Schonfeld Strategic Advisors
New York
$13.4M
4
VPC
4
Vestal Point Capital
New York
$0
5
CAM
5
Cormorant Asset Management
Massachusetts
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Balyasny Asset Management
26
Balyasny Asset Management
Illinois
$2.76M 604,749 +519,633 +610%
TI
27
Trexquant Investment
Connecticut
$2.69M 588,417 -47,430 -7%
PAI
28
Palo Alto Investors
California
$2.63M 575,817 – –
Charles Schwab
29
Charles Schwab
California
$2.6M 568,184 -2,534 -0.4%
Dimensional Fund Advisors
30
Dimensional Fund Advisors
Texas
$2.04M 444,509 +7,420 +2%
Two Sigma Investments
31
Two Sigma Investments
New York
$1.73M 379,581 -190,723 -33%
AQR Capital Management
32
AQR Capital Management
Connecticut
$1.71M 373,207 +340,143 +1,029%
IC
33
Ikarian Capital
Texas
$1.64M 358,393 +188,402 +111%
JPMorgan Chase & Co
34
JPMorgan Chase & Co
New York
$1.44M 316,179 -101,360 -24%
Citadel Advisors
35
Citadel Advisors
Florida
$1.42M 311,480 +182,278 +141%
SFI
36
Susquehanna Fundamental Investments
Pennsylvania
$1.3M 284,237 -7,146 -2%
Wellington Management Group
37
Wellington Management Group
Massachusetts
$1.12M 244,183 -117,315 -32%
Bank of New York Mellon
38
Bank of New York Mellon
New York
$1.03M 225,034 +4,532 +2%
GCP
39
GSA Capital Partners
United Kingdom
$996K 217,927 +78,768 +57%
Barclays
40
Barclays
United Kingdom
$855K 186,968 -33,763 -15%
Renaissance Technologies
41
Renaissance Technologies
New York
$826K 180,800 -182,600 -50%
Two Sigma Advisers
42
Two Sigma Advisers
New York
$794K 173,800 -119,400 -41%
ACP
43
Acuta Capital Partners
California
$744K 162,724 +2,524 +2%
PHS
44
PFM Health Sciences
California
$711K 155,495 +29,496 +23%
American Century Companies
45
American Century Companies
Missouri
$690K 150,876 +23,412 +18%
Stifel Financial
46
Stifel Financial
Missouri
$664K 145,377 +4,235 +3%
Mirae Asset Global ETFs Holdings
47
Mirae Asset Global ETFs Holdings
Hong Kong
$647K 140,727 -4,022 -3%
Citigroup
48
Citigroup
New York
$644K 140,870 +22,436 +19%
UBS AM
49
UBS AM
Illinois
$610K 133,566 +13,748 +11%
UBS Group
50
UBS Group
Switzerland
$602K 131,773 -8,016 -6%
1
2
3 4 5